United Health Products, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UEEC research report →
Companywww.unitedhealthproductsinc.com
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding.
- CEO
- Brian D. Thom
- IPO
- 2007
- Employees
- 7
- HQ
- Mount Laurel, NV, US
Price Chart
Valuation
- Market Cap
- $14.10M
- P/E
- -9.70
- P/S
- 0.00
- P/B
- -3.36
- EV/EBITDA
- -15.38
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 39.88%
- ROIC
- 48.50%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-2,669,348 · -33.35%
- EPS
- $-0.01 · -28.40%
- Op Income
- $-2,255,474
- FCF YoY
- 0.65%
Performance & Tape
- 52W High
- $0.23
- 52W Low
- $0.04
- 50D MA
- $0.06
- 200D MA
- $0.07
- Beta
- -0.29
- Avg Volume
- 164.17K
Get TickerSpark's AI analysis on UEEC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 8, 25 | Thom Brian David | buy | 32,000 |
| Mar 31, 25 | Thom Brian David | buy | 18,000 |
| May 12, 23 | Thom Brian David | sell | 300,000 |
| Apr 17, 23 | Thom Brian David | other | 309,375 |
| Dec 31, 22 | Heaton Kristofer | other | 0 |
| Jan 13, 23 | Thom Brian David | other | 225,000 |
| Dec 31, 22 | Thom Brian David | other | 0 |
| Sep 16, 22 | Thom Brian David | other | 150,000 |
| Jun 2, 22 | Thom Brian David | sell | 127,100 |
| Jun 3, 22 | Thom Brian David | sell | 56,055 |
Our UEEC Coverage
We haven't published any research on UEEC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate UEEC Report →